Urinary Tract Infection Treatment Market to Attain a Value of US$ 11.58 Bn by 2026

The global Urinary tract infection treatment market was valued at US$ 9.2 Bn in 2015, and is projected to expand at a CAGR of 2.1% over forecast period 2016–2026, owing to increasing incidence of UTIs and recurring UTIs, increasing use of urinary catheters, and other drainage devices.

The global urinary tract infection treatment market is segmented on the basis of drug type, indication, distribution channel and region.

The global urinary tract infection treatment market is segmented into penicillin & combinations, quinolones, cephalosporin, aminoglycoside antibiotics, sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, and other segments.

By indication, the global urinary tract infection treatment market is segmented into complicated urinary tract infection, recurring complicated urinary tract infection, uncomplicated urinary tract infection, and neurogenic bladder infection. The neurogenic bladder infections indication segment is expected to expand at a CAGR of 2.6% in terms of revenue over the forecast period.

By distribution channel, the global urinary tract infection treatment market is segmented into hospital pharmacies, gynecology and urology clinics, drug store, retail pharmacies, and online drug stores. The online drug stores distribution channel segment is expected to expand at a CAGR of 2.8% in terms of revenues over the forecast period.

The global urinary tract infection treatment market has been segmented into seven major regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Japan and Middle East & Africa (MEA). Revenue from the North America market is expected to expand at a CAGR of 2.0% over the forecast period. In North America, the quinolones segment is expected to register a CAGR of 2.6% to reach value of US$ 695.4 Mn by 2026 end.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1340

Summary of Table of Content:

1.Assumptions and Acronyms Used

2.Research Methodology

3.Executive Summary

4.Urinary Tract Infection Treatment Market Overview

5.Global Urinary Tract Infection Treatment Market Analysis, By Drug Type

6.Global Urinary Tract Infection Treatment Market Analysis, By Distribution Channel

7.Global Urinary Tract Infection Treatment Market Analysis, By Indication

8.Global Urinary Tract Infection Treatment Market Analysis, By Region

9.North America Urinary Tract Infection Treatment Market Analysis

10. Latin America Urinary Tract Infection Treatment Market Analysis

11. Western Europe Urinary Tract Infection Treatment Market Analysis

12. Eastern Europe Urinary Tract Infection Treatment Market Analysis

14. Japan Urinary Tract Infection Treatment Market Analysis

15. MEA Urinary Tract Infection Treatment Market Analysis

16. Competition Landscape

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/urinary-tract-infections-market/toc

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Website:  http://www.futuremarketinsights.com

Advertisements

Companion Animal Vaccines Market to Attain a Value of US$ 4,500 Mn by 2026

The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026.

The Global Companion Animal Vaccines Market is segmented on the basis of species type, product type, distribution channel and region.

The Canine species segment is anticipated to register a 6.9% CAGR over the forecast period and be valued at nearly US$ 2,500 Mn by 2026 end.

Attenuated Live Vaccines will Continue to Witness Highest Demand. Nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.

In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.

The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.

Request A Sample Request: https://www.futuremarketinsights.com/reports/sample/rep-gb-1427

Summary of Table of Content

1. Executive Summary

2. Market Introduction

3. Companion Animal Vaccines Market Analysis Scenario

4. Companion Animal Vaccines Market Dynamics

5. Global Companion Animal Vaccines Market Analysis and Forecast, By Product Type

6. Global Companion Animal Vaccines Market Analysis and Forecast, By Distribution Channel

7. Global Companion Animal Vaccines Market Analysis and Forecast, By Species Type

8. Global Companion Animal Vaccines Market Analysis and Forecast, By Region

9. North America Companion Animal Vaccines Market Analysis and Forecast

10. Latin America Companion Animal Vaccines Market Analysis and Forecast

11. Western Europe Companion Animal Vaccines Market Analysis and Forecast

12. Eastern Europe Companion Animal Vaccines Market Analysis and Forecast

13. Asia Pacific Excl. Japan (APEJ) Companion Animal Vaccines Market Analysis and Forecast

14. Japan Companion Animal Vaccines Market Analysis and Forecast

15. MEA Companion Animal Vaccines Market Analysis and Forecast

16. Competition Landscape

17. Assumptions and Acronyms Used

18. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market/toc

Outpatient Clinics Market to Attain a Value of US$ 39,000 Mn by 2027

Growing advancements in medical technology has led to development of treatment techniques and medications that do not require the patients to stay for long hours at the clinics or hospitals. However, imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period. Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Read Report Preview: https://www.futuremarketinsights.com/reports/outpatient-clinics-market

Factors Fuelling Global Market Growth

Growth of the global outpatient clinics market is mainly bound to various macro-economic and micro-economic factors. Prevalence of chronic diseases such as asthma, diabetes, depression and congestive heart failures lead to complex and severe health problems. With the escalating cost of treatment process in various healthcare organizations, patients prefer visiting the outpatient clinics for accessing treatment. Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases and cerebrovascular diseases has further led to surge in demand for the outpatient clinics globally.

Demand for quick and effective treatment of cardiovascular diseases will continue to contribute towards the global market growth of outpatient disorders. According to a recently published report by CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths. As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment process will continue to remain high. These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5697

Collaborations among the private insurance companies and outpatient clinics will continue to remain a major trend in the global market. Through collaborations the private insurance companies offer payment and services in outpatient clinics. Imposition of regulations such as Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides the U.S. citizens with the public health insurance coverage and offers access to private health insurance services. Moreover, increasing employee benefits such as Employees’ health insurance by the employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.

However, the global market of outpatient clinics will continue to witness inhibiting growth attributed to various factors. Imposition of strict regulations and limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics. As the patients are not monitored for a long period of time, risk of addiction to alcohol and drugs is projected to remain high. Moreover, lack of access to counselors in comparison to the residential and inpatient facility is further projected to impede the global market growth of outpatient clinics.

Buy Outpatient Clinics Market Research Report: https://www.futuremarketinsights.com/checkout/5697

Sales to Remain High Through Cardiology Specialty Areas

Prevalence of chronic and cardiovascular disorders is projected to fuel demand for the multi-specialty centers globally. In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end. Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

On the basis of specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022. However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Market Players

Major players in the global market of outpatient clinics are Kaiser Permanente Inc., M D Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering, University of Maryland Medical Center, DaVita Inc., Cleveland Clinic, Fresenius Medical Care and Johns Hopkins Medicine.

 

Sleep Apnea Diagnostic System Market is Expanding at a CAGR of 7.3% by 2026

Future Market Insights delivers key insights on the global sleep apnea diagnostic system market in its upcoming report titled “Sleep Apnea Diagnostic System Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” The global sleep apnea diagnostic system market is estimated to exhibit a 7.3% CAGR by value during the assessed period, owing to numerous factors, about which Future Market Insights offers thorough insights and forecasts in this report.

Under the polysomnography devices, ambulatory PSG monitoring devices and clinical PSG monitoring devices are the two sub-segments that contribute to the polysomnography (PSG) devices. To provide in-depth insights on the pattern of demand defining the global sleep apnea diagnostic system market, the market is segmented into different types of end users. The home care settings segment is likely to witness a significant CAGR of 8.0% in the next 10 years in value terms. The actigraphy monitoring device product type segment is estimated to register a significant value CAGR of more than 8% during the forecast period.

Read Report Preview: https://www.futuremarketinsights.com/reports/sleep-apnea-diagnostic-system-market

The factors powering demand for sleep apnea diagnostic systems are increasing healthcare expenditure on home care testing equipment and wearable devices. Increasing prevalence of obstructive sleep apnea is likely to lead to significant growth in cost incurred for treatment of sleep apnea, which is anticipated to create demand for more advanced devices for diagnosis of sleep apnea. Reimbursement companies adopt a more favorable policy towards HST over in-lab testing. Thus, rising demand for equipment and wearable devices used in HST testing is in turn expected to drive global sleep apnea diagnostic system market growth. Chronic snoring is a strong indicator of sleep apnea. Factors that can affect sleep quality include sleep biology, circadian rhythm, and shift work. Sleep can also be disturbed due to tension, depression and fatigue. These factors in turn are expected to positively impact the sleep apnea diagnostic system market during the projected period.

However, most patients suffering from sleep apnea do not know the difference between general sleeping disorders and normal snoring problems. Moreover, most patients are inclined towards symptomatic treatment. This is projected to inhibit the global sleep apnea diagnostic system market growth in the next few years.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-777

Segmentation analysis

  • Portable monitoring is used as an alternative test for obstructive sleep apnea as it is less expensive on account of its portability and requires less space. Also, it is quicker to initiate the process as compared to in-laboratory polysomnography testing. Owing to its usability as a device for ambulatory testing, the polysomnography segment is likely to witness moderate growth in the coming years.
  • The home care settings segment is projected to witness robust growth due to better patient compliance as compared to the in-labs testing segment.

Regional analysis

Due to high obesity rates and improper lifestyles, the adoptability of sleep apnea services are higher in the North America region. Introduction of updated devices and owing to the simple and easy process of their regulatory approval, the market in North America is creating a positive impact on the global sleep apnea diagnostic system market.

Buy Sleep Apnea Diagnostic System Market Research Report: https://www.futuremarketinsights.com/checkout/777

This report assesses trends driving the growth of each segment of the global as well as regional markets and offers potential takeaways that could prove substantially useful to sleep apnea diagnostic system manufacturers looking to enter the global sleep apnea diagnostic system market. The North America market has been estimated to dominate the global sleep apnea diagnostic system market, accounting for maximum revenue share of the market by 2016 end. Collectively, North America and Western Europe markets are expected to account for approximately 66% revenue share of global sleep apnea diagnostic system market by 2016 end. Western Europe is projected to exhibit a significant CAGR of 7.4% between 2016 and 2026, followed by the Japan sleep apnea diagnostic systems market.

Vendor insights

Some of the leading companies operating in the global sleep apnea diagnostic system market include SOMNOmedics GmbH, Dickinson and Company, Braebon Medical Corporation, Advanced Brain Monitoring, Inc., Becton, Natus Medical Incorporated, MGC Diagnostics Corporation, Cleveland Medical Devices Inc., Koninklijke Philips N.V.,BMC Medical Co, Ltd., and ResMed Inc.

 

3D Printed Medical Devices Market is Expanding at a CAGR of 17.7% by 2026

Future Market Insights delivers key insights on the global 3D printed medical devices market in a new publication titled “3D Printed Medical Devices Market: Global Industry Analysis and Opportunity Assessment, 2016 – 2026”. The global 3D printed medical devices market was estimated to be US$ 238 Mn in 2015 and it has a wide scope of growth in the forecast period. The global 3D printed medical devices market can be broadly classified into six segments depending on the technology namely – stereolithography (SLA), selective layer sintering (SLS), digital light processing (DLP), fused deposition modelling (FDM), polyjet / inkjet 3D printing, and electronic beam melting (EBM) – each with different applications that are specific to orthopaedic, dental, and internal and external prosthetics. The global 3D printed medical devices market is expected to reach US$ 279.6 Mn in 2016, witnessing a year-on-year growth of 17.5%.

Read Report Preview: https://www.futuremarketinsights.com/reports/3d-Printed-medical-devices-market

According to Future Market Insights analysts, factors such as a rising prevalence of disorders such as diabetes-related gangrene cases, peripheral vascular diseases, and osteoarthritis among elderly individuals are leading to the use of 3D printed medical devices. Some of the other factors are cases where dental implants and cranio-maxillofacial implants are required. These factors are collectively anticipated to fuel the revenue growth of the global 3D printed medical devices market over the forecast period. In addition, factors such as rising awareness regarding personal care, increasing prevalence of chronic diseases, increase in incidence of accidents, and increasing geriatric population are anticipated to enhance the growth of the global 3D printed medical devices market over the forecast period.

However, only a few selected materials such as resins, plastics and a few metals are used for 3D printing. Usage of other materials for 3D printing results in high operational costs and is time consuming. Also, size of the printer limits the size of the product and thus, it is a challenging job to produce parts of large industrial machines. Moreover, a key limiting factor in the adoption of 3D printing are technical barriers. These are complex equipment and so most of the 3D printing manufacturers are utilising open source technology. As adjusting equipment and printing parameters are time consuming processes, users lose interest in learning or knowing to operate such devices.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1501

Segmentation highlights

By technology, the SLS technology segment accounted for a higher revenue share in the global 3D printed medical devices market in 2015 as compared to other product segments. The SLS technology segment is expected to reach a value of US$ 230.0 Mn by 2026, registering a CAGR of 15.3% over the forecast period. Though the value of the polyjet / inkjet 3D printed medical devices technology segment was lower as compared to the SLS technology segment in 2015, due to a growing demand and increasing applications, its value over the forecast period is expected to be the highest amongst the other categories in the technology segment.

By material, the plastics material segment accounted for a higher revenue share in the global 3D printed medical devices market as compared to others. The plastic material segment is expected to reach a value of US$ 984.7 Mn by 2026, registering a CAGR of 17.2% over the forecast period.

By application, the orthopaedic implants application segment accounted for a higher revenue share in the global 3D printed medical devices market as compared to other segments. The orthopaedic implants application segment is expected to reach a value of US$ 643.5 Mn by 2026, reflecting a CAGR of 19.9% over the forecast period.

Buy 3D Printed Medical Devices Market Research Report: https://www.futuremarketinsights.com/checkout/1501

By distribution channel, the hospitals end user segment accounts for higher demand for 3D printed medical devices as compared to other distribution channel segments such as ambulatory surgical centres and diagnostic centres, registering a CAGR of 18.7% over the forecast period.

Regional market projections

Sales of 3D printed medical devices are relatively healthy in the U.S. market in recent years, making North America the most lucrative market globally. The North America 3D printed medical devices market revenue was accounted to be US$ 105.0 Mn in 2015, with the U.S. accounting for a majority of revenue share. In addition to North America, 3D printed medical devices sales are expected to grow gradually in Western Europe, Eastern Europe, and APEJ. Revenues in Western Europe are expected to register a CAGR of 18.5%, whereas Eastern Europe is anticipated to register a CAGR of 15.6% over the forecast period.

Vendor insights

Key players in the global 3D printed medical devices market include 3D Systems, Inc., Arcam AB, Stratasys Ltd., FabRx Ltd., EOS GmbH Electro Optical Systems, EnvisionTEC, Cyfuse Biomedical K.K., and Bio3D Technologies. Major market players are implementing different strategies and are launching new products in order to grow their market share.